SNY acquires PRNB @$100/sh in cash—a 10% premium to Friday’s closing price: https://www.globenewswire.com/news-release/2020/08/17/2078993/0/en/Sanofi-to-acquire-Principia-Biopharma.html The deal’s enterprise value (excluding PRNB’s cash in hand) is $3.36B.